glutamic acid and piperazine

glutamic acid has been researched along with piperazine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Grover, LM; Teyler, TJ1
Ahring, PK; Gajhede, M; Hald, H; Kastrup, JS; Liljefors, T; Timmermann, DB1
Hao, M; Li, G; Li, Y; Wang, Y; Yan, Y; Yang, L; Zhang, S1

Other Studies

4 other study(ies) available for glutamic acid and piperazine

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Different mechanisms may be required for maintenance of NMDA receptor-dependent and independent forms of long-term potentiation.
    Synapse (New York, N.Y.), 1995, Volume: 19, Issue:2

    Topics: Action Potentials; Animals; Calcium; Glutamic Acid; Hippocampus; Long-Term Potentiation; Neural Pathways; Piperazine; Piperazines; Protein Kinases; Receptors, N-Methyl-D-Aspartate

1995
Distinct structural features of cyclothiazide are responsible for effects on peak current amplitude and desensitization kinetics at iGluR2.
    Journal of molecular biology, 2009, Sep-04, Volume: 391, Issue:5

    Topics: Allosteric Regulation; Animals; Antihypertensive Agents; Benzothiadiazines; CHO Cells; Cricetinae; Cricetulus; Crystallography, X-Ray; Dimerization; Glutamic Acid; Models, Molecular; Molecular Sequence Data; Molecular Structure; Patch-Clamp Techniques; Piperazine; Piperazines; Protein Structure, Quaternary; Rats; Receptors, AMPA

2009
Combined 3D-QSAR, molecular docking, and molecular dynamics study on piperazinyl-glutamate-pyridines/pyrimidines as potent P2Y12 antagonists for inhibition of platelet aggregation.
    Journal of chemical information and modeling, 2011, Oct-24, Volume: 51, Issue:10

    Topics: Biological Availability; Glutamic Acid; Heterocyclic Compounds, 1-Ring; Humans; Molecular Dynamics Simulation; Piperazine; Piperazines; Platelet Aggregation; Protein Conformation; Purinergic P2Y Receptor Antagonists; Pyridines; Pyrimidines; Quantitative Structure-Activity Relationship; Receptors, Purinergic P2Y12; Reproducibility of Results

2011